×

Year 2020
Yoo SH, Kwon JH*. The interplay between direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C. Hepatoma Research 2020;6:9
Yoo SH, Kwon JH* et al. Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-flurouracil versus sorafenib for hepatocellular carcinoma with refractoriness of transarterial chemoembolization using doxorubicin. Cancer Control 2020, accepted in article
Kim MA, Kim SU, Sinn DH, Jang JW, Lim YS, Ahn SH, Shim JJ, Seo YS, Baek YH, Kim SG, Kim YS, Kim JH, Choe WH, Yim HJ, Lee HW, Kwon JH, Lee SW, Jang JY, Kim HY, Park Y, Kim GA, Yang H, Lee HA, Koh M, Lee YS, Kim M, Chang Y, Kim YJ, Yoon JH, Zoulim F, Lee JH. Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study. Gut. 2020 Online ahead of print.
Year 2019
Lee SW#, Kwon JH#, Lee HL, Yoo SH, Nam HC, Sung PS, Nam SW, Bae SH, Choi JY, Yoon SK, Han NI, Jang JW. Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naive patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis. Gut. 2019 Oct 31. pii: gutjnl-2019-318947. doi: 10.1136/gutjnl-2019-318947. [Epub ahead of print]
Kwon JH, Song MJ, Jang JW, et al. Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea. Dig Dis Sci. 2019 Jul;64(7):2039-2048.
Kwon JH, Yoo SH, Nam SW, et al. Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea. J Med Virol. 2019 Jun;91(6):1104-1111.
Yoo SH, Kwon JH*. New Potential Therapies for Chronic Hepatitis B. Korean J Gastroenterol. 2019 Nov 25;74(5):267-273.
Lee HW, Park JY, Kim SG, Tak WY, Yim HJ, Jang BK, Kim MY, Kim BI, Lee JW, Yoon KT, Cheong JY, Kwon SY, Kim TY, Bae SH, Seo YS, Kwon JH, Kim DJ, Kim JK, Jeong SW, Myoung S, Ahn SH, Han KH; Soul Study Group. Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection. Clin Gastroenterol Hepatol. 2019 Dec;17(13):2811-2813.e1
Joo YY, Jang JW, Lee SW, Yoo SH, Kwon JH, Nam SW, Bae SH, Choi JY, Yoon SK. Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression. Sci Rep. 2019 Jun 24;9(1):9137
Nam HC, Sung PS, Song DS, Kwon JH, Nam SW, Yoon DJ, Jang JW, Choi JY, Yoon SK, Moon SW, Jang HS, Park JS, Jeun SS, Hong YK, Bae SH. Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma. Int J Clin Oncol. 2019 Jun;24(6):666-676.
Jang JW, Yoo SH, Nam HC, Jang BH, Sung PS, Lee SW, Kwon JH, Nam SW, Bae SH, Yoon SK, Choi JY. Association of prophylactic anti-HBV therapy with improved long-term survival in patients with hepatocellular carcinoma undergoing transarterial therapy. Clin Infect Dis. 2019 Sep 1:ciz860.
Lee HL, Jang JW, Lee SW, Yoo SH, Kwon JH, Nam SW, Bae SH, Choi JY, Han NI, Yoon SK. Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Sci Rep. 2019 Mar 1;9(1):3260.
Year 2018
Kwon JH*. The Role of Serum HBV-RNA Levels as a Marker of Intrahepatic Viral and Histologic Activity. Korean J Gastroenterol. 2018 May 25;71(5):297-299.
Kwon JH, I. Hanouneh, D. Allende, L. Yerian, T. Diago, B. Eghtesad, and N.N. Zein. A De Novo Autoimmune Hepatitis Following Liver Transplantation. Transplantation proceedings 2018;50:1451-1456
Yoo SH, Kwon JH*, Nam SW, et al. Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: comparison with pegylated interferon-based therapy in chronic hepatitis C patients. J Viral Hepat. 2018 ;25:1189-1196
Kim YW, Kwon JH, Nam SW, Jang JW, Jung HS, Shin YR, Park ES, Shim DJ. Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. Exp Ther Med. 2018 Feb;15(2):1479-1483. doi: 10.3892/etm.2017.5540. Epub 2017 Nov 22.
Jekarl DW, Choi H, Lee S, Kwon JH, Lee SW, Yu H, Kim M, Kim Y, Sung PS, Yoon SK. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients. Ann Lab Med. 2018 Jul;38(4):348-354. doi: 10.3343/alm.2018.38.4.348.
Yoon YC, Lee JS, Park SU, Kwon JH, Hong TH, Kim DG. Quantitative assessment of liver fibrosis using shore durometer. Ann Surg Treat Res. 2017 Dec;93(6):300-304. doi: 10.4174/astr.2017.93.6.300. Epub 2017 Dec 1.
Kim H, Kwon JH*, Kim YH, Nam SW, Lee JY, Jang JW. Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B. Clin Mol Hepatol. 2017 Nov 27. doi: 10.3350/cmh.2017.0016. [Epub ahead of print]
Lee SW, Lee HL, Han NI, Kwon JH, Nam SW, Jang JW, Bae SH, Choi JY, Yoon SK. Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis. Ther Adv Med Oncol. 2017 Oct;9(10):615-626. doi: 10.1177/1758834017728018. Epub 2017 Aug 29
Year 2017
Jung Hyun Kwon*. The Role of Tenofovir on the Prevention of Hepatitis B Transmission in Mothers with High Viral Load Korean J Gastroenterol 2017; 69(3): 199~201